What is the most likely diagnosis for a patient with acute agitation, verbal abuse, uncooperative and manipulative behavior, persecutory delusions toward a relative, claiming a benzodiazepine overdose, requiring four‑point restraints, and normal vital signs?

Differential Diagnosis: Substance-Induced Psychotic Disorder vs. Benzodiazepine Withdrawal Delirium

The most likely diagnosis is benzodiazepine withdrawal delirium, given the patient's claim of benzodiazepine overdose (which may actually represent abrupt cessation), combined with acute agitation, persecutory delusions, and normal vital signs. 1

Clinical Reasoning

Primary Diagnostic Considerations

The presentation of acute agitation with persecutory delusions, manipulative behavior, and normal vital signs in the context of reported benzodiazepine use creates two competing diagnostic possibilities:

1. Benzodiazepine Withdrawal Delirium (Most Likely)

• The patient's claim of "benzodiazepine overdose" may be misleading—this could represent recent discontinuation or dose reduction rather than actual overdose
• Benzodiazepine withdrawal delirium characteristically presents with agitation, hallucinations, and persecutory delusions, typically in a hyperactive form 1
• Onset occurs 12 hours to 13 days after dose changes, most commonly from abrupt discontinuation 1
• Normal vital signs do not exclude this diagnosis, as delirium can present with subtle disturbances in consciousness 2
• Delirium is a medical emergency with mortality rates twice as high if missed 2

2. Substance-Induced Psychotic Disorder (Alternative)

• Acute substance-induced psychotic disorder commonly presents with agitation in an acute delusional setting 3
• However, true benzodiazepine overdose typically causes sedation, not agitation
• Paradoxical benzodiazepine-induced psychosis exists but is extremely rare 4

Critical Diagnostic Algorithm

Step 1: Assess for Delirium Features

• Evaluate for inattention (cardinal feature of delirium) 2
• Look for fluctuating consciousness throughout the day with lucid intervals 2
• Determine if symptoms are acute onset (hours to days) versus chronic

Step 2: Obtain Substance Use History

• Document duration and dose of benzodiazepine use (withdrawal risk increases with chronic use, especially >6 weeks) 1
• Identify timing of last dose or any recent dose reduction
• Screen for polysubstance use (alcohol, opioids commonly co-occur) 5
• Assess for patterns of substance abuse behavior: noncompliance, malingering, medication-seeking 5

Step 3: Rule Out Medical Causes

• Point-of-care glucose (mandatory) 6
• Consider metabolic, infectious, neurologic etiologies given that 46% of psychiatric presentations have underlying medical causes 7
• Normal vital signs are reassuring but do not exclude organic pathology 7

Immediate Management Approach

Pharmacologic Control of Agitation

For this uncooperative patient requiring restraints, use parenteral medication:

First-Line Options (Level B Evidence):

• Benzodiazepine monotherapy: Lorazepam 2-4 mg IM or midazolam 7

  • Paradoxically, this is appropriate even if withdrawal is suspected—reinitiation of benzodiazepines is the primary treatment for withdrawal delirium and leads to complete symptom resolution 1

• Conventional antipsychotic monotherapy: Haloperidol 5 mg IM or droperidol (if rapid sedation needed) 7

Combination Therapy (Level C Evidence):

• Parenteral benzodiazepine + haloperidol may produce more rapid sedation than monotherapy 7

Critical Pitfall to Avoid

Do NOT withhold benzodiazepines based solely on the patient's claim of "overdose." If this is actually withdrawal delirium, benzodiazepine reinitiation is curative 1. The patient's cognitive abilities and clinical presentation—not their self-report—should guide treatment 7.

Disposition and Ongoing Management

• Psychiatric admission is likely required (71% of substance-related agitation cases with severe behavioral disturbance require admission) 8
• If benzodiazepine withdrawal is confirmed, reinitiate the original agent or substitute, which resolves symptoms in 92% of cases 1
• Period of observation to determine if psychiatric symptoms resolve as intoxication/withdrawal resolves 7
• Reconcile medication history to prevent iatrogenic withdrawal in inpatient settings 1

Special Considerations

The manipulative and persecutory behavior toward family may represent:

• Delirium-related behavioral disturbance (most likely if acute onset)
• Substance abuse-related malingering patterns 5
• Underlying psychiatric disorder unmasked by substance use

The severity of agitation (requiring 4-point restraints) independently predicts psychiatric admission and suggests severe behavioral instability requiring inpatient stabilization 8.